PHARMA SIGNALOPEN RESEARCH PLATFORM →
COMPANY RESEARCH PROFILE · UPDATED 2026-09-29

QIAGEN

Molecular-diagnostics company providing sample-to-insight technologies, syndromic testing, and companion diagnostics used in clinical care and biopharmaceutical development.

TICKERQGEN
HEADQUARTERSVenlo, Netherlands
STAGECommercial
ACTIVE TRIALS3

Therapeutic areas

OncologyInfectious DiseaseCompanion Diagnostics

Selected products and programs

therascreenQIAstat-DxQuantiFERON

Linked curated drug profiles

No curated drug entity is linked in the current pilot.

Selected active clinical trials

DHF-20-1839-2: Clinical Performance Study Protocol for Therascreen® KRAS RGQ PCR Kit

NA · Recruiting · Metastatic Colorectal Cancer (mCRC)

Clinical Performance of QIAstat-Dx® Meningitis/Encephalitis (ME) Panel Plus

NA · Active Not Recruiting · Meningitis

Clinical Performance Evaluation of the QIAstat-Dx® cUTI Plus AMR

NA · Active Not Recruiting · Complicated Urinary Tract Infection

Selected patent records

No linked FDA Orange Book patent record was found for the selected products.

Primary and company sources

Company and pipeline information can change. Verify material decisions against the linked primary sources.

Evidence & limits

Source: Open the source record

Record identifier
/companies/qiagen/
Event / action date
Not separately retained
Source update date
Not separately retained
Platform retrieval / processing date
Not separately retained

What it supports. Connections found through the catalog, identifiers, or name and alias matching, with source links where retained.

Limits. A company association is not proof of ownership or sponsorship of every linked record. Product, substance, parent-company, and subsidiary relationships may differ.

Connection basis. Catalog, identifier, or normalized name association. Product and company connections are research leads, not ownership determinations.

What this record means · Report an issue with this record